Good morning, everyone. Nice to see you again after a day in which jury duty loomed. Now, though, we are back to resume the usual routine. And this calls for a cup of stimulation. So please join us as you brace for that familiar round of meetings and deadlines. To help you along, here are a few interesting items. Have a great day...
Roche Sales Slide As Avastin Falters (Reuters)
Glaxo Gives WHO 'De-Worming' Pills For Children (Dow Jones)
Osteoporosis Drugs Require Fracture Warnings (Bloomberg News)
Glaxo Loses Tyverb Appeal to UK's NICE (WebMD)
Labs Lure Scientist To Keep Ideas In St. Louis (St. Louis Post Dispatch)
San Diego Biotechs Turn Profitable (San Diego Union Tribune)
Merck Pushes 'Green Cubed' Strategy In Korea (Korea Times)
Coffee pix thx to chichcacha flickr creative commons